Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy

Brain Research
Peter M CliffordRobert G Nagele

Abstract

Deposition of beta-amyloid (Abeta) peptides in the walls of brain blood vessels, cerebral amyloid angiopathy (CAA), is common in patients with Alzheimer's disease (AD). Previous studies have demonstrated Abeta peptide deposition among vascular smooth muscle cells (VSMCs), but the source of the Abeta and basis for its selective deposition in VSMCs are unknown. In the present study, we examined the deposition patterns of Abeta peptides, Abeta40 and Abeta42, within the cerebrovasculature of AD and control patients using single- and double-label immunohistochemistry. Abeta40 and Abeta42 were abundant in VSMCs, especially in leptomeningeal arteries and their initial cortical branches; in later-stage AD brains this pattern extended into the microvasculature. Abeta peptide deposition was linked to loss of VSMC viability. Perivascular leak clouds of Abeta-positive material were associated primarily with arterioles. By contrast, control brains possessed far fewer Abeta42- and Abeta40-immunopositive blood vessels, with perivascular leak clouds of Abeta-immunopositive material rarely observed. We also demonstrate that VSMCs in brain blood vessels express the alpha7 nicotinic acetylcholine receptor (alpha7nAChR), which has high binding aff...Continue Reading

References

Jan 1, 1987·Virchows Archiv. A, Pathological Anatomy and Histopathology·A DelacourteM C Peers
Aug 1, 1987·Journal of Neurology·M YamadaM Hayakawa
Sep 8, 1995·The Journal of Biological Chemistry·J Davis-Salinas, W E Van Nostrand
Feb 15, 1993·Archives of Biochemistry and Biophysics·D L MillerK Iqbal
Jan 7, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·M M EsiriJ H Morris
Apr 12, 2000·Progress in Neurobiology·D Paterson, A Nordberg
Apr 14, 2000·Brain Research. Molecular Brain Research·L BurghausH Schröder
May 20, 2000·Annals of the New York Academy of Sciences·H M WisniewskiJ Frackowiak
May 20, 2000·Annals of the New York Academy of Sciences·P BurgermeisterM Jucker
Nov 3, 2001·Brain Research. Brain Research Reviews·S M GloorK Frei
Jul 12, 2002·Journal of Neural Transmission·K A Jellinger
Sep 25, 2003·Neurological Research·Roy O Weller, James A Nicoll
Oct 24, 2003·Brain Research. Brain Research Reviews·Annemieke A M RensinkMarcel M Verbeek
Nov 18, 2003·The Journal of Clinical Investigation·Joachim Herz
Dec 5, 2003·Acta Neuropathologica·Johannes Attems, Kurt A Jellinger
Jan 28, 2004·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Maki UjiieWilfred A Jefferies
May 14, 2004·Journal of Neurochemistry·Berislav V Zlokovic
Jul 22, 2004·Neurological Research·Jack C de la Torre
Sep 18, 2004·Stroke; a Journal of Cerebral Circulation·Philip B Gorelick
Oct 2, 2004·Stroke; a Journal of Cerebral Circulation·Steven M GreenbergEric E Smith
Jul 27, 2005·Journal of Neuropathology and Experimental Neurology·Sarah B DomnitzMatthew P Frosch
Mar 1, 2007·Annals of Neurology·Marieke van OijenMonique M B Breteler

❮ Previous
Next ❯

Citations

May 13, 2009·Archives of Neurology·Milos D IkonomovicSteven T Dekosky
Feb 19, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Caterina M HernandezKelly T Dineley
Feb 4, 2010·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·M R D'Andrea, R G Nagele
Aug 12, 2009·Neuroscience and Biobehavioral Reviews·Peter DomeZoltan Rihmer
Dec 18, 2009·Journal of Neurochemistry·Jacek LichotaTorben Moos
Jul 25, 2013·The Journal of Comparative Neurology·Sylvia E PerezElliott J Mufson
Apr 26, 2013·The Biochemical Journal·Maddalena Costanzo, Chiara Zurzolo
Dec 19, 2014·Brain Pathology·Roy O WellerRoxana O Carare
Mar 28, 2019·Annual Review of Biochemistry·Jaime Vaquer-Alicea, Marc I Diamond
Jan 12, 2021·Frontiers in Physiology·Ildernandes Vieira-AlvesVirgínia Soares Lemos
Aug 20, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jennifer M CoughlinMartin G Pomper
Dec 24, 2021·Seminars in Thrombosis and Hemostasis·Tamara K StevensonDaniel A Lawrence

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.